Zoomedia Blog

Our clients know that the litany of negative headlines from the financial sector in the past month has not escaped the eyes and minds of marketing departments budget crunchers throughout the life sciences. In response to the economic uncertainty, many biotech and pharma companies are cutting non-core spending to maintain internal stability. Reduced budgets present the proverbial challenge that "tools are needed to build a ship." Yet marketers are charged with delivering the corporate or product message out, building sales and partnerships, and developing brand awareness. In this catch-22, how can the industry best stretch its marketing dollars?

Tags: SEM, RSS, Online Marketing, Viral Marketing, Product Strategy, Investor Strategy, Clinical Trial Strategy

In a time when most conversations I have with clients revolve around how the global economical state of affairs is going to affect their marketing budgets for 2009, my response has been clear and unchanged - it's time to smarten up. Investors are more critical than ever on fiscal performance, managers have to keep close control of their spending and report on results, all of which is compounded by the FDA who is starting to crack down on claims made within DTC advertising. We have to stay focused, and more than ever, find ways to be efficient and strategic with our initiatives.

Tags: Online Marketing, Viral Marketing, DTC Advertising, Product Strategy, Global Strategy, Investor Strategy